SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-1.04%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$541M
AUM Growth
+$541M
(-11%)
Cap. Flow
-$24.3M
Cap. Flow
% of AUM
-4.49%
Top 10 Holdings %
Top 10 Hldgs %
32.22%
Holding
125
New
17
Increased
28
Reduced
37
Closed
22
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$8.28M |
| 2 |
Annexon
ANNX
|
$6.38M |
| 3 |
Ormat Technologies
ORA
|
$5.35M |
| 4 |
Eledon Pharmaceuticals
ELDN
|
$5.17M |
| 5 |
SolarEdge
SEDG
|
$5.1M |
Top Sells
| 1 |
Apple
AAPL
|
$14.2M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$12.4M |
| 3 |
Amazon
AMZN
|
$9.43M |
| 4 |
SentinelOne
S
|
$6.62M |
| 5 |
Nice
NICE
|
$6.09M |
Sector Composition
| 1 | Healthcare | 74.91% |
| 2 | Technology | 16.21% |
| 3 | Communication Services | 3.96% |
| 4 | Consumer Discretionary | 2.54% |
| 5 | Utilities | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Oric Pharmaceuticals
ORIC
$1.02B
| $2.2M | 0.4% |
273,213
+144,817
| +113% | +$1.17M |
|
|
CMMB
77
Chemomab Therapeutics
CMMB
$15.6M
| $2.2M | 0.4% |
1,214,575
| – | – |
|
78
Xenon Pharmaceuticals
XENE
$2.99B
| $2.04M | 0.37% |
+52,097
| New | +$2.04M |
|
79
ProMIS Neurosciences
PMN
$25.4M
| $1.83M | 0.33% |
1,929,297
| – | – |
|
80
Uber
UBER
$194B
| $1.81M | 0.33% |
+30,000
| New | +$1.81M |
|
81
Larimar Therapeutics
LRMR
$330M
| $1.76M | 0.32% |
455,604
+41,126
| +10% | +$159K |
|
82
Zura Bio
ZURA
$131M
| $1.73M | 0.31% |
690,718
-48,000
| -6% | -$120K |
|
|
SHLT
83
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
| $1.68M | 0.3% |
632,456
| – | – |
|
84
Perspective Therapeutics
CATX
$250M
| $1.47M | 0.27% |
460,247
-129,048
| -22% | -$412K |
|
85
Astria Therapeutics
ATXS
$387M
| $1.25M | 0.23% |
139,800
+3,218
| +2% | +$28.8K |
|
86
Bristol-Myers Squibb
BMY
$96.5B
| $1.13M | 0.2% |
+20,000
| New | +$1.13M |
|
87
Mersana Therapeutics
MRSN
$35.3M
| $987K | 0.18% |
+690,272
| New | +$987K |
|
|
ALMS
88
Alumis Inc. Common Stock
ALMS
$483M
| $983K | 0.18% |
125,000
| – | – |
|
89
Werewolf Therapeutics
HOWL
$62.2M
| $928K | 0.17% |
626,810
| – | – |
|
90
Aprea Therapeutics
APRE
$8.91M
| $888K | 0.16% |
270,000
| – | – |
|
91
Perion Network
PERI
$417M
| $869K | 0.16% |
102,612
-131,997
| -56% | -$1.12M |
|
|
OKUR
92
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.4M
| $751K | 0.14% |
+87,354
| New | +$751K |
|
93
Kezar Life Sciences
KZR
$28.6M
| $729K | 0.13% |
108,473
-96,695
| -47% | -$650K |
|
94
Fate Therapeutics
FATE
$115M
| $655K | 0.12% |
+397,177
| New | +$655K |
|
95
Alector
ALEC
$272M
| $614K | 0.11% |
324,639
-295,361
| -48% | -$558K |
|
|
ELEV
96
DELISTED
Elevation Oncology
ELEV
| $573K | 0.1% |
1,018,562
-61,200
| -6% | -$34.4K |
|
|
CLYM
97
Climb Bio, Inc. Common Stock
CLYM
$164M
| $453K | 0.08% |
251,935
+69,965
| +38% | +$126K |
|
98
Kyverna Therapeutics
KYTX
$155M
| $444K | 0.08% |
118,758
-129,893
| -52% | -$486K |
|
99
Compugen
CGEN
$133M
| $271K | 0.05% |
177,094
-50,000
| -22% | -$76.5K |
|
100
LAVA Therapeutics
LVTX
$41.6M
| $120K | 0.02% |
126,328
-20,129
| -14% | -$19.1K |
|